GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (FRA:1RT) » Definitions » Net Interest Income

Nuformix (FRA:1RT) Net Interest Income : €0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nuformix Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Nuformix's net interest income for the six months ended in Sep. 2024 was €0.00 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Nuformix Net Interest Income Historical Data

The historical data trend for Nuformix's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Net Interest Income Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only -0.02 - - - -

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nuformix Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix Net Interest Income Related Terms

Thank you for viewing the detailed overview of Nuformix's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (FRA:1RT) » Definitions » Net Interest Income
Comparable Companies
LSE:BSFA LSE:PYC LSE:VAL LSE:ONC LSE:ROQ LSE:CRTX LSE:GENF LSE:TCF LSE:APTA AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NFX:UK 1RT:Germany
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.nuformix.com
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix Headlines

No Headlines